PT-141, also known as Bremelanotide, is a synthetic peptide derived from the melanocortin peptide family. It has been studied in scientific and clinical research for its interaction with melanocortin receptors, particularly those located in the central nervous system.

In laboratory and experimental studies, PT-141 has been investigated for its ability to activate melanocortin receptors such as MC3 and MC4, which are involved in neurological signaling pathways that regulate several physiological processes. These receptors play roles in neuroendocrine signaling and central nervous system communication.

Scientific research has explored how PT-141 may influence pathways associated with neurotransmitter activity, hormonal signaling, and neurological responses. Because of its receptor-targeting mechanism, PT-141 continues to be studied in research focused on the melanocortin system and its broader role in human physiology.

Ongoing investigations aim to further understand the compound’s interaction with melanocortin receptors and its effects on central nervous system signaling pathways.

Disclaimer:
This product is intended strictly for laboratory research purposes only. It is not approved for human consumption, medical use, or therapeutic applications.